The development of sex differences in cardiovascular disease mortality: a historical perspective

S V Nikiforov1, V B Mamaev

  • 1Division of Environmental Health Science, Columbia Unviersity School of Public Health, New York, NY, USA.

Insights

Historically, males did not always have higher cardiovascular disease (CVD) mortality rates than females. This study reveals distinct stages in CVD sex differences, with male excess mortality appearing later in the historical record.

Area of Science:

  • Epidemiology
  • Public Health
  • Cardiovascular Disease Research

Background:

  • Cardiovascular disease (CVD) mortality rates are higher in males than females, but the historical origins of this disparity are unclear.
  • Understanding the historical context of sex differences in CVD mortality is crucial for identifying underlying causes.

Purpose of the Study:

  • To investigate historical trends in cardiovascular disease (CVD) mortality differences between males and females.
  • To determine if male excess CVD mortality has consistently existed throughout the historical record.

Main Methods:

  • Analysis of mortality statistics for cardiovascular disease (CVD) in England and Wales (1861-1992) and the United States (1900-1991).
  • Examination of CVD mortality trends across the full range of age groups over time.

Main Results:

  • Three distinct stages were identified in the relationship between male and female CVD mortality.
  • These stages include an initial period of equal mortality, followed by the emergence of sex differences, and finally, consistent male excess mortality.
  • Male excess mortality from CVD is a relatively recent phenomenon in the historical data.

Conclusions:

  • Male excess mortality from cardiovascular disease (CVD) is not a constant historical feature.
  • Further research is necessary to understand the factors contributing to the current male excess CVD mortality.
Abstract

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...